Low-cost and clinically applicable copy number profiling using repeat DNA

Autor: S Jammula, A Lynch, Yeng Ang, Charles Crichton, Andrew D Beggs, T Hupp, van Lanschot Mcv., S Puig, F Ciccarelli, L Lovat, E. Fidziukiewicz, J Bornschein, N Carroll, M Lewis, J Owsley, S Abujudeh, R D la Rue, M Tripathi, A J Metz, H Barr, A Miremadi, Jason Crawte, Shaun R. Preston, S Oakes, C Peters, Simon Tavaré, Juliane Perner, O Tucker, B Kumar, C Harden, V Goh, G Devonshire, S Hayes, P Safranek, Laszlo Igali, Andy G. Lynch, J Zylstra, Barbara Nutzinger, Oesophageal Cancer Clinical, A Noorani, I Bagwan, J Gossage, A Davies, A. Northrop, Irshad Soomro, Jim Davies, X Li, Shalini Malhotra, Nicola Grehan, G Sanders, P Kaye, Lawrence Bower, P Taniere, V Save, Edwards Paw., Christopher C.W. Hughes, Rehan Haidry, S Parsons, E Cheong, A Hindmarsh, N Shepherd, Ula Mahadeva, Edward Morrissey, J Saunders, F Chang, M Eldridge, Maria O'Donovan, R O’Neill, S Lishman, S S Zeki, Michael F. Scott, G Hanna, T Underwood, Weaver Jmj., Rebecca C. Fitzgerald, M Pusung, S Sothi, Maria Secrier, S Suortamo, R Berrisford, Skipworth Rje., Shona MacRae, F Noble, R Fitzgerald, J Lagergren, A Grabowska, O Old, V Sujendran, R Turkington, Gianmarco Contino

Large-scale cancer genome studies suggest that tumors are driven by somatic copy number alterations (SCNAs) or single-nucleotide variants (SNVs). Due to the low-cost, the clinical use of genomics assays is biased towards targeted gene panels, which i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1841052f772eaaa01655d5864053eda
https://doi.org/10.1101/394429

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.